Filed: 11/15/2024ACC: 0001104659-24-119361
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 26 equity positions with a total reported market value of $422.19M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
26
Positions
$422.19M
Total AUM (reported)
49.72M
Total Shares
Allocation by class
COM$401.09M95.0%
SHS$11.35M2.7%
ADR$5.29M1.3%
COM CL A$4.40M1.0%
WARRANTS$63.2K0.0%
Portfolio Concentration
Top 3$288.75M68.4%
4–10$80.76M19.1%
11–25$52.62M12.5%
Rest$63.2K0.0%
Top 3 weight
68.4%
Top 10 weight
87.5%
Voting Authority Distribution
Total shares with voting rights: 49.07M
Sole
Full voting authority
49.07M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole26
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings26
Rows:
CG ONCOLOGY INC
SOLEShares5.48M
TypeSH
Market value$206.72M
48.96%
Sole
5.48M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares25.95M
TypeSH
Market value$59.44M
14.08%
Sole
25.95M
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares1.25M
TypeSH
Market value$22.60M
5.35%
Sole
1.25M
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares869.79K
TypeSH
Market value$13.30M
3.15%
Sole
869.79K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares71.77K
TypeSH
Market value$13.06M
3.09%
Sole
71.77K
Shared
0.00
None
0.00
Illumnia, Inc.
SOLEShares94.77K
TypeSH
Market value$12.36M
2.93%
Sole
94.77K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares3.11M
TypeSH
Market value$11.44M
2.71%
Sole
3.11M
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares4.96M
TypeSH
Market value$11.35M
2.69%
Sole
4.96M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares590K
TypeSH
Market value$9.79M
2.32%
Sole
590K
Shared
0.00
None
0.00
MERUS NV
SOLEShares189.10K
TypeSH
Market value$9.45M
2.24%
Sole
189.10K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares166.60K
TypeSH
Market value$8.40M
1.99%
Sole
166.60K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares157.96K
TypeSH
Market value$8.07M
1.91%
Sole
157.96K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP-ADR
SOLEShares108.56K
TypeSH
Market value$5.29M
1.25%
Sole
108.56K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares94.04K
TypeSH
Market value$4.97M
1.18%
Sole
94.04K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares515.55K
TypeSH
Market value$4.59M
1.09%
Sole
515.55K
Shared
0.00
None
0.00
GeneDx Holdings Corp.
SOLEShares103.60K
TypeSH
Market value$4.40M
1.04%
Sole
103.60K
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares397.83K
TypeSH
Market value$4.30M
1.02%
Sole
397.83K
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$3.70M
0.88%
Sole
4.45M
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares69.77K
TypeSH
Market value$3.08M
0.73%
Sole
69.77K
Shared
0.00
None
0.00
LONGBOARD PHARMACEUTICALS IN
SOLEShares56.35K
TypeSH
Market value$1.88M
0.44%
Sole
56.35K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares21.18K
TypeSH
Market value$1.77M
0.42%
Sole
21.18K
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$1.20M
0.28%
Sole
326.81K
Shared
0.00
None
0.00
AtriCure Inc.
SOLEShares26.80K
TypeSH
Market value$751.4K
0.18%
Sole
26.80K
Shared
0.00
None
0.00
GRAIL INC
SOLEShares9.68K
TypeSH
Market value$133.3K
0.03%
Sole
9.68K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC(NSM)
SOLEShares2K
TypeSH
Market value$90.7K
0.02%
Sole
2K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 5.48M | SH | $206.72M 48.96% | 5.48M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $59.44M 14.08% | 25.95M | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 1.25M | SH | $22.60M 5.35% | 1.25M | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 869.79K | SH | $13.30M 3.15% | 869.79K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 71.77K | SH | $13.06M 3.09% | 71.77K | 0.00 | 0.00 |
Illumnia, Inc.SOLE | COM | 94.77K | SH | $12.36M 2.93% | 94.77K | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 3.11M | SH | $11.44M 2.71% | 3.11M | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 4.96M | SH | $11.35M 2.69% | 4.96M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 590K | SH | $9.79M 2.32% | 590K | 0.00 | 0.00 |
MERUS NVSOLE | COM | 189.10K | SH | $9.45M 2.24% | 189.10K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | COM | 166.60K | SH | $8.40M 1.99% | 166.60K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 157.96K | SH | $8.07M 1.91% | 157.96K | 0.00 | 0.00 |
LEGEND BIOTECH CORP-ADRSOLE | ADR | 108.56K | SH | $5.29M 1.25% | 108.56K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM | 94.04K | SH | $4.97M 1.18% | 94.04K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 515.55K | SH | $4.59M 1.09% | 515.55K | 0.00 | 0.00 |
GeneDx Holdings Corp.SOLE | COM CL A | 103.60K | SH | $4.40M 1.04% | 103.60K | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 397.83K | SH | $4.30M 1.02% | 397.83K | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $3.70M 0.88% | 4.45M | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | COM | 69.77K | SH | $3.08M 0.73% | 69.77K | 0.00 | 0.00 |
LONGBOARD PHARMACEUTICALS INSOLE | COM | 56.35K | SH | $1.88M 0.44% | 56.35K | 0.00 | 0.00 |
ARCELLX INCSOLE | COM | 21.18K | SH | $1.77M 0.42% | 21.18K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $1.20M 0.28% | 326.81K | 0.00 | 0.00 |
AtriCure Inc.SOLE | COM | 26.80K | SH | $751.4K 0.18% | 26.80K | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 9.68K | SH | $133.3K 0.03% | 9.68K | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 2K | SH | $90.7K 0.02% | 2K | 0.00 | 0.00 |
Page 1 of 2